The 20 Best Pulmonary Hypertension Doctors Near Me in New Brunswick, NJ

Kishan Parikh is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Raleigh, North Carolina. Dr. Parikh is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure, Hypertension, and Heart Transplant. Dr. Parikh is currently accepting new patients.

Vallerie Mclaughlin is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Mclaughlin is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Hypertension, Systemic Sclerosis (SSc), Angioplasty, and Cardiac Ablation. Dr. Mclaughlin is board certified in Cardiovascular Disease.

Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Systemic Sclerosis (SSc), Cerebral Hypoxia, Pulmonary Veno-Occlusive Disease, and Lung Transplant. Dr. Hassoun is board certified in American Board Of Internal Medicine.

Dr. Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.After receiving his medical degree from Yale University School of Medicine, Dr. Waxman completed a residency in internal medicine at Yale New Haven Hospital. He then completed two fellowships: the first at Howard Hughes Medical Institute, and the second in pulmonary and critical care at Yale New Haven Hospital. He is board certified in critical care medicine, internal medicine and pulmonary disease.Dr. Waxman’s clinical interests include pulmonary arterial hypertension (PAH), right heart failure, thromboembolic disease and pulmonary vascular disease. His research focuses on the inflammatory mechanisms of pulmonary vascular remodeling that lead to right heart failure. His research into the regulation of cell death proteins by IL-6 cytokines in mice led to the discovery of a relationship between dyspnea and mitochondrial dysfunction, and resulted in additional clinical studies examining the abnormalities of inflammatory mediators and oxygen extraction in patients with PAH. He has authored over 110 peer-reviewed publications and has received funding from the National Institutes of Health and the National Heart, Lung, and Blood Institute. Dr. Waxman is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Interstitial Lung Disease, Thrombectomy, and Lung Transplant. Dr. Waxman is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Adriano Tonelli is an Intensive Care Medicine provider practicing medicine in Cleveland, Ohio. Dr. Tonelli is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, Acute Interstitial Pneumonia, and Lung Transplant.

Marc Simon is a Cardiologist practicing medicine in San Francisco,, California. Dr. Simon is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Heart Failure, Pulmonary Veno-Occlusive Disease, and Heart Transplant.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant. Dr. Mathai is board certified in American Board Of Internal Medicine.

Oksana A. Shlobin, MD, FCCP, serves as Medical Director for the Pulmonary Hypertension Program and Director of Outreach and Education for the Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital. She is also an Associate Professor of Clinical Medicine at Georgetown University School of Medicine and an Associate Clinical Professor of Medicine at the University of Virginia. Dr. Shlobin is board certified in pulmonary and critical care medicine. Dr. Shlobin has been actively involved in clinical research both during her fellowship and her tenure at Inova. She is co-author of multiple publications, including original research manuscripts, abstracts and book chapters. Her research interests include pulmonary hypertension and interstitial lung diseases. Blog Posts What is Pulmonary Hypertension? Learn the Facts to Breathe Easy (November 2018) Pulmonary Hypertension is Serious. Learn to Spot the Signs (May 2017). Dr. Shlobin is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Endoscopy.

Paul Forfia is a Cardiologist practicing medicine in Philadelphia,, Pennsylvania. Dr. Forfia is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Pulmonary Veno-Occlusive Disease, Angioplasty, and Embolectomy.

Murali Chakinala is an Intensive Care Medicine provider practicing medicine in Saint Louis, Missouri. Dr. Chakinala is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Arteriovenous Malformation, Pulmonary Veno-Occlusive Disease, Acute Interstitial Pneumonia, and Lung Transplant.

Bradley Maron is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Maron is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Heart Failure, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Ioana Preston is an Intensive Care Medicine provider practicing medicine in Boston, Massachusetts. Dr. Preston is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Cerebral Hypoxia, and Lung Transplant.

I take care of patients with pulmonary hypertension (PH). I also research signaling pathways that are altered in the development of PH in rodent models of the disease. PH covers a wide spectrum of diseases, from the rare pulmonary arterial hypertension (prevalence of 15 in one million) to complications of more common heart and lung disease. PH typically leads to complications through its effects on the heart, leading to heart failure. At the Duke Center for Pulmonary Vascular Disease we see a number of patients with PH and offer all available therapies, including continuous intravenous infusion, inhaled therapies, and surgical options. Dr. Rajagopal is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Pulmonary Veno-Occlusive Disease, Embolectomy, and Angioplasty. Dr. Rajagopal is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Cardiovascular Disease.

Raed Dweik is an Intensive Care Medicine provider practicing medicine in Cleveland, Ohio. Dr. Dweik is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Cerebral Hypoxia, Asthma, Beryllium Disease, and Lung Transplant. Dr. Dweik is board certified in American Board Of Internal Medicine, 1997.

Brian Graham is an Intensive Care Medicine provider practicing medicine in Aurora, Colorado. Dr. Graham is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Cerebral Hypoxia, Pulmonary Veno-Occlusive Disease, and Pneumonia.

James Klinger is an Intensive Care Medicine provider practicing medicine in Providence, Rhode Island. Dr. Klinger is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Chronic Obstructive Pulmonary Disease (COPD).

Teresa De is a Cardiologist practicing medicine in San Francisco,, California. She has been practicing medicine for over 44 years. Dr. De is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Hypertension, Pulmonary Veno-Occlusive Disease, Heart Transplant, and Splenectomy.

Roxana Sulica is an Intensive Care Medicine provider practicing medicine in New York, New York. Dr. Sulica is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Acute Interstitial Pneumonia.

Peter Leary is a Cardiologist and a Pulmonary Medicine provider practicing medicine in Seattle, Washington. Dr. Leary is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Sarcoidosis, Angioplasty, and Lung Transplant.

I enjoy advancing medicine through academics and excellent patient care. Dr. Rischard is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Systemic Sclerosis (SSc). Dr. Rischard is board certified in American Board Of Internal Medicine/Critical Care Medicine and American Board Of Internal Medicine/Pulmonary Disease. Dr. Rischard is currently accepting new patients.